{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:03:40Z","timestamp":1784077420161,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Arvid Nilssons Foundation"},{"name":"Bispebjerg and Frederiksberg Hospitals\u2019 Internal Research Grants"},{"name":"Else and Mogens Wedell-Wedellsborg\u2019s Foundation"},{"name":"Inge and J\u00f8rgen Larsen\u2019s Memorial Foundation"},{"name":"Meirion Thomas Cancer Research Trust"},{"name":"NEYE Foundation"},{"DOI":"10.13039\/501100023331","name":"LEO Pharma A\/S","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pharmacosmos A\/S"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lundbeck Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52722-1","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:44:26Z","timestamp":1778744666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumour location and mismatch repair status impact gene expression profiles associated with lymph node metastases in T1 colon cancers"],"prefix":"10.1038","volume":"16","author":[{"given":"Anders L.","family":"Ebbeh\u00f8j","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars N.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi","family":"Chiranth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linea C.","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Litman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Martin","family":"Krarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"52722_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006355","author":"AL Ebbeh\u00f8j","year":"2024","unstructured":"Ebbeh\u00f8j, A. L., J\u00f8rgensen, L. N., Smith, H. G. & Krarup, P. M. Current management of T1 colon cancer in Denmark. Ann. Surg. https:\/\/doi.org\/10.1097\/sla.0000000000006355 (2024).","journal-title":"Ann. Surg."},{"key":"52722_CR2","doi-asserted-by":"publisher","first-page":"E148","DOI":"10.1097\/SLA.0000000000003854","volume":"275","author":"CF Ronnow","year":"2022","unstructured":"Ronnow, C. F. et al. Lymphovascular infiltration, not depth of invasion, is the critical risk factor of metastases in early colorectal cancer: retrospective population-based cohort study on prospectively collected data, including validation. Ann. Surg. 275, E148\u2013E154 (2022).","journal-title":"Ann. Surg."},{"issue":"12","key":"52722_CR3","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1016\/j.cgh.2020.05.060","volume":"18","author":"JH Yeh","year":"2020","unstructured":"Yeh, J. H. et al. Long-term outcomes of primary endoscopic resection vs surgery for T1 colorectal cancer: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 18(12):2813-2823 (2020). https:\/\/doi.org\/10.1016\/j.cgh.2020.05.060 doi:10.1016\/j.cgh.2020.05.060.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"52722_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/j.gastro.2022.04.010","volume":"163","author":"LW Zwager","year":"2022","unstructured":"Zwager, L. W. et al. Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis. Gastroenterology 163, 174\u2013189 (2022).","journal-title":"Gastroenterology"},{"key":"52722_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S2468-1253(21)00368-X","volume":"7","author":"ECH Breekveldt","year":"2022","unstructured":"Breekveldt, E. C. H. et al. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study. Lancet Gastroenterol. Hepatol. 7, 60\u201368 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"52722_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2018.03.062","volume":"155","author":"MB Larsen","year":"2018","unstructured":"Larsen, M. B., Njor, S., Ingeholm, P. & Andersen, B. Effectiveness of colorectal cancer screening in detecting earlier-stage disease\u2014a nationwide cohort study in Denmark. Gastroenterology 155, 99\u2013106 (2018).","journal-title":"Gastroenterology"},{"key":"52722_CR7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/gutjnl-2011-300843","volume":"61","author":"RFA Logan","year":"2012","unstructured":"Logan, R. F. A. et al. Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut 61, 1439\u20131446 (2012).","journal-title":"Gut"},{"key":"52722_CR8","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s, G. et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann. Oncol. 31, 1291\u20131305 (2020).","journal-title":"Ann. Oncol."},{"key":"52722_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/bjs.10979","volume":"106","author":"H Elfeki","year":"2019","unstructured":"Elfeki, H. et al. Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life. Br. J. Surg. 106, 142\u2013151 (2019).","journal-title":"Br. J. Surg."},{"key":"52722_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S2468-1253(22)00248-5","volume":"7","author":"Q Feng","year":"2022","unstructured":"Feng, Q. et al. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol. Hepatol. 7, 991\u20131004 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"52722_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/codi.14710","volume":"21","author":"A Thy\u00f8","year":"2019","unstructured":"Thy\u00f8, A., Elfeki, H., Laurberg, S. & Emmertsen, K. J. Female sexual problems after treatment for colorectal cancer\u2014a population-based study. Colorectal Dis. 21, 1130\u20131139 (2019).","journal-title":"Colorectal Dis."},{"key":"52722_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/a-0831-2522","volume":"51","author":"C Hassan","year":"2019","unstructured":"Hassan, C. et al. Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European society of gastrointestinal endoscopy (ESGE) and European society of digestive oncology (ESDO) guideline. Endoscopy 51, 266\u2013277 (2019).","journal-title":"Endoscopy"},{"key":"52722_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/DCR.0000000000002323","volume":"65","author":"JD Vogel","year":"2022","unstructured":"Vogel, J. D. et al. The American society of colon and rectal surgeons clinical practice guidelines for the management of colon cancer. Dis. Colon Rectum. 65, 148\u2013177 (2022).","journal-title":"Dis. Colon Rectum"},{"key":"52722_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi, Y. et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int. J. Clin. Oncol. 25, 1\u201342 (2020).","journal-title":"Int. J. Clin. Oncol."},{"key":"52722_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/DCR.0b013e31826942ee","volume":"56","author":"KM Kim","year":"2013","unstructured":"Kim, K. M. et al. Risk factors for residual cancer and lymph node metastasis after noncurative endoscopic resection of early colorectal cancer. Dis. Colon Rectum. 56, 35\u201342 (2013).","journal-title":"Dis. Colon Rectum"},{"key":"52722_CR16","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1245\/s10434-012-2471-7","volume":"19","author":"H Kobayashi","year":"2012","unstructured":"Kobayashi, H. et al. Resection with en bloc removal of regional lymph node after endoscopic resection for T1 colorectal cancer. Ann. Surg. Oncol. 19, 4161\u20134167 (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"52722_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.21873\/invivo.11596","volume":"33","author":"K Iguchi","year":"2019","unstructured":"Iguchi, K. et al. Additional surgical resection after endoscopic resection for patients with high-risk T1 colorectal cancer. Vivo (Brooklyn). 33, 1243\u20131248 (2019).","journal-title":"Vivo (Brooklyn)"},{"key":"52722_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/gutjnl-2016-312201","volume":"67","author":"CH Richards","year":"2018","unstructured":"Richards, C. H. et al. An evidence-based treatment algorithm for colorectal polyp cancers: Results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS). Gut 67, 299\u2013306 (2018).","journal-title":"Gut"},{"key":"52722_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cgh.2016.08.041","volume":"15","author":"TDG Belderbos","year":"2017","unstructured":"Belderbos, T. D. G. et al. Long-term recurrence-free survival after standard endoscopic resection versus surgical resection of submucosal invasive colorectal cancer: a population-based study. Clin. Gastroenterol. Hepatol. 15, 403\u2013411e1 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"52722_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1053\/j.gastro.2017.11.275","volume":"154","author":"T Ozawa","year":"2018","unstructured":"Ozawa, T. et al. A MicroRNA signature associated with metastasis of T1 colorectal cancers to lymph nodes. Gastroenterology 154, 844\u2013848e7 (2018).","journal-title":"Gastroenterology"},{"key":"52722_CR21","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1053\/j.gastro.2019.02.027","volume":"156","author":"R Kandimalla","year":"2019","unstructured":"Kandimalla, R. et al. Gene expression signature in surgical tissues and endoscopic biopsies identifies high-risk T1 colorectal cancers. Gastroenterology 156, 2338\u20132341e3 (2019).","journal-title":"Gastroenterology"},{"key":"52722_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1053\/j.gastro.2021.03.062","volume":"161","author":"Y Wada","year":"2021","unstructured":"Wada, Y. et al. A liquid biopsy assay for noninvasive identification of lymph node metastases in T1 colorectal cancer. Gastroenterology 161, 151\u2013162e1 (2021).","journal-title":"Gastroenterology"},{"issue":"1","key":"52722_CR23","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1038\/s41598-024-55139-w","volume":"14","author":"I Ciepiela","year":"2024","unstructured":"Ciepiela, I. et al. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients. Sci. Rep. 14 (1), 4619 (2024).","journal-title":"Sci. Rep."},{"key":"52722_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejso.2014.11.001","volume":"41","author":"GH Lee","year":"2015","unstructured":"Lee, G. H. et al. Is right-sided colon cancer different to left-sided colorectal cancer?\u2014A systematic review. Eur. J. Surg. Oncol. 41, 300\u2013308 (2015).","journal-title":"Eur. J. Surg. Oncol."},{"key":"52722_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi, M. et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med. 26, 566\u2013576 (2020).","journal-title":"Nat. Med."},{"key":"52722_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/cancers15041022","volume":"15","author":"N Mulet-Margalef","year":"2023","unstructured":"Mulet-Margalef, N. et al. Challenges and Therapeutic Opportunities in the dMMR\/MSI-H Colorectal Cancer Landscape. Cancers (Basel). 15, 1022 (2023).","journal-title":"Cancers (Basel)"},{"key":"52722_CR27","unstructured":"Hamilton, S. R. & Aaltonen, L. A. Pathology and Genetics of Tumours of the Digestive System. (2000)."},{"key":"52722_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/0016-5085(85)90333-6","volume":"89","author":"RC Haggitt","year":"1985","unstructured":"Haggitt, R. C., Glotzbach, R. E., Soffer, E. E. & Wruble, L. D. Prognostic factors in colorectal carcinomas arising in adenomas: Implications for lesions removed by endoscopic polypectomy. Gastroenterology 89, 328\u2013336 (1985).","journal-title":"Gastroenterology"},{"key":"52722_CR29","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/BF02049154","volume":"38","author":"R Kikuchi","year":"1995","unstructured":"Kikuchi, R. et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis. Colon Rectum. 38, 1286\u20131295 (1995).","journal-title":"Dis. Colon Rectum"},{"issue":"1","key":"52722_CR30","doi-asserted-by":"publisher","first-page":"9349132","DOI":"10.1155\/2020\/9349132","volume":"2020","author":"T Matsubara","year":"2020","unstructured":"Matsubara, T. et al. DV200 Index for assessing RNA integrity in next-generation sequencing. Biomed. Res. Int. 2020 (1), 9349132 (2020).","journal-title":"Biomed. Res. Int."},{"key":"52722_CR31","unstructured":"Storey, J. D., Tibshirani, R. & Green, P. P. Statistical significance for genomewide studies. In Proceedings of the national academy of sciences https:\/\/www.pnas.org\/doi\/10.1073\/pnas.1530509100"},{"key":"52722_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","volume":"98","author":"S Ram\u00f3n y Cajal","year":"2020","unstructured":"Ram\u00f3n y Cajal, S. et al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J. Mol. Med. 98, 161\u2013177 (2020).","journal-title":"J. Mol. Med."},{"key":"52722_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/bjs\/znab168","volume":"108","author":"AL Ebbeh\u00f8j","year":"2021","unstructured":"Ebbeh\u00f8j, A. L., J\u00f8rgensen, L. N., Krarup, P. M. & Smith, H. G. Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis. Br. J. Surg. 108, 769\u2013776 (2021).","journal-title":"Br. J. Surg."},{"key":"52722_CR34","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/codi.17049","volume":"26","author":"HG Smith","year":"2024","unstructured":"Smith, H. G., Schlesinger, N. H., Krarup, P. M. & Nordholm-Carstensen, A. Current treatment of pT1 rectal cancers in Denmark: A retrospective national cohort study. Colorectal Dis. 26, 1175\u20131183 (2024).","journal-title":"Colorectal Dis."},{"key":"52722_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","volume":"53","author":"F Benedix","year":"2010","unstructured":"Benedix, F. et al. Comparison of 17,641 patients with right- and left-sided colon cancer: Differences in epidemiology, perioperative course, histology, and survival. Dis. Colon Rectum. 53, 57\u201364 (2010).","journal-title":"Dis. Colon Rectum"},{"key":"52722_CR36","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1245\/s10434-008-0015-y","volume":"15","author":"RA Meguid","year":"2008","unstructured":"Meguid, R. A., Slidell, M. B., Wolfgang, C. L. & Chang, D. C. Ahuja, N. Is there a difference in survival between right- versus left-sided colon cancers? Ann. Surg. Oncol. 15, 2388\u20132394 (2008).","journal-title":"Ann. Surg. Oncol."},{"key":"52722_CR37","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1080\/15384047.2015.1113356","volume":"16","author":"WS El-Deiry","year":"2015","unstructured":"El-Deiry, W. S. et al. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. Cancer Biol. Ther. 16, 1726\u20131737 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"52722_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"DM Muzny","year":"2012","unstructured":"Muzny, D. M. et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"52722_CR39","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","volume":"390","author":"M Chalabi","year":"2024","unstructured":"Chalabi, M. et al. Neoadjuvant immunotherapy in locally advanced mismatch repair\u2013deficient colon cancer. N. Engl. J. Med. 390, 1949\u20131958 (2024).","journal-title":"N. Engl. J. Med."},{"key":"52722_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006611","author":"I G\u00f6genur","year":"2024","unstructured":"G\u00f6genur, I. et al. Neoadjuvant pembrolizumab in stage I-III deficient mismatch repair colon cancer: A clinical trial. Ann. Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000006611 (2024).","journal-title":"Ann. Surg."},{"key":"52722_CR41","doi-asserted-by":"crossref","unstructured":"Chen, B. et al. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. J. Exper. Clin. Cancer Res. 36, (2017).","DOI":"10.1186\/s13046-017-0522-4"},{"key":"52722_CR42","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1038\/onc.2014.69","volume":"33","author":"IH Lee","year":"2014","unstructured":"Lee, I. H. et al. Ahnak functions as a tumor suppressor via modulation of TGF\u03b2\/Smad signaling pathway. Oncogene 33, 4675\u20134684 (2014).","journal-title":"Oncogene"},{"key":"52722_CR43","doi-asserted-by":"publisher","first-page":"23579","DOI":"10.18632\/aging.203473","volume":"13","author":"Y Cai","year":"2021","unstructured":"Cai, Y. et al. AHNAK suppresses ovarian cancer progression through the Wnt\/\u03b2-catenin signaling pathway. Aging (Albany NY). 13, 23579 (2021).","journal-title":"Aging (Albany NY)"},{"issue":"27","key":"52722_CR44","first-page":"6","volume":"27","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics. Cell. Death Differ. 27 (27), 6 (2019).","journal-title":"Cell. Death Differ."},{"key":"52722_CR45","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1080\/15548627.2021.2008690","volume":"18","author":"TG Keulers","year":"2022","unstructured":"Keulers, T. G. et al. ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer. Autophagy 18, 1898\u20131914 (2022).","journal-title":"Autophagy"},{"key":"52722_CR46","first-page":"1704","volume":"60","author":"J Mollenhauer","year":"2000","unstructured":"Mollenhauer, J. et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 60, 1704\u20131710 (2000).","journal-title":"Cancer Res."},{"key":"52722_CR47","doi-asserted-by":"publisher","first-page":"47076","DOI":"10.18632\/oncotarget.16792","volume":"8","author":"J Garay","year":"2017","unstructured":"Garay, J. et al. Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies. Oncotarget 8, 47076\u201347089 (2017).","journal-title":"Oncotarget"},{"key":"52722_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/path.6406","volume":"266","author":"EH Green","year":"2025","unstructured":"Green, E. H. et al. Multiomic spatial atlas shows deleted in malignant brain tumors 1 (DMBT1) glycoprotein is lost in colonic dysplasia. J. Pathol. 266, 51\u201365 (2025).","journal-title":"J. Pathol."},{"key":"52722_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/cbf.3549","volume":"38","author":"N Ma","year":"2020","unstructured":"Ma, N. & Zhao, Y. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3\/PI3k\/Akt pathway. Cell. Biochem. Funct. 38, 801\u2013809 (2020).","journal-title":"Cell. Biochem. Funct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52722-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52722-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52722-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:03:37Z","timestamp":1784073817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52722-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52722"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52722-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Krarup has received personal fees and served as proctor and speaker for Intuitive Surgical and received a research grant from Pharmacosmos A\/S. Professor Litman is funded by LEO Pharma A\/S. Dr Smith has received research grants from The Lundbeck Foundation, The Novo Nordisk Foundation, and The NEYE Foundation. The remaining authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22079"}}